BIOSPECIFICS TECHNOLOGIES CORP 4/A
4/A · BIOSPECIFICS TECHNOLOGIES CORP · Filed Feb 3, 2017
Insider Transaction Report
Form 4/AAmended
Wegman Thomas
DirectorPresident10% Owner
Transactions
- Sale
Common Stock, $.001 par value
2016-12-08$49.54/sh−15,000$743,112→ 277,549 total
Footnotes (2)
- [F1]The selling price of $49.5408 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $49.20 to $50.13. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]The purpose of this Form 4/A is solely to correct the amount of securities beneficially owned by the reporting person and does not represent any acquisition or disposition of shares by the reporting person.